As of 3:59pm ET
| +0.12 / +1.98%|
The 3 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.50, with a high estimate of 24.00 and a low estimate of 8.00. The median estimate represents a +85.78% increase from the last price of 6.19.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.